Neuronal cell-cycle re-entry stratifies clinical trajectories in amyotrophic lateral sclerosis
Brain · 11.11.2026
DOI: 10.1093/brain/awag391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 11.11.2026. Verfasst von Jonathan Plessis-Belair und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology and Behavior; Stony Brook University, Stony Brook, NY 11794, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
The clinical heterogeneity of Amyotrophic Lateral Sclerosis (ALS) remains a fundamental barrier to effective therapy. While cell cycle re-entry in post-mitotic neurons is a known precursor to neurodegeneration, its role in defining patient-specific outcomes has never been established. Here, we integrate large-scale transcriptomic profiling from the AnswerALS cohort with mechanistic studies in human iPSC-derived spinal motor neurons to define how cell-cycle re-entry shapes disease heterogeneity in ALS. We identify a transcriptionally distinct patient subgroup with the highest expression of G1 or G2-phase cyclins that exhibit significantly slower functional decline (ALSFRS-R), whereas the engagement of S-phase markers correlates with accelerated disease progression. Nucleocytoplasmic transport dysfunction, a hallmark of ALS and related disorders, disrupts the spatial distribution of key regulatory proteins and may contribute to maladaptive cell-cycle activation. Our recent evidence suggests that impaired nuclear import may initiate, rather than merely accompany, neuronal cell-cycle re-entry. Using iPSC-derived motor neurons, we show that impaired nuclear import initiates TDP-43 pathology and global nuclear/cytoplasmic mis-localization of key ALS-related proteins. This nucleocytoplasmic transport dysfunction triggers a transient wave of cell-cycle activity immediately preceding neuronal cell death. Crucially, we show that DNA-replication initiation is a pathological inflection point of no return, as neurons entering S-phase accumulate replication-associated DNA damage and undergo cell death. Selective inhibition of CDK4/6 prevents S-phase entry and confers potent neuroprotection. Our findings demonstrate that impaired nuclear import drives maladaptive cell-cycle reactivation in ALS and that the depth of cell-cycle engagement stratifies neuronal fate and patient trajectories.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurobiology and Behavior; Stony Brook University, Stony Brook, NY 11794, USA.
- Center for Nervous System Disorders; Stony Brook University, Stony Brook, NY 11794, USA.
ORCID-Profile: Roger B Sher
Zitieren
APA
Plessis-Belair, J., & Sher, R. B. (2026). Neuronal cell-cycle re-entry stratifies clinical trajectories in amyotrophic lateral sclerosis. Brain. https://doi.org/10.1093/brain/awag391
Vancouver
Plessis-Belair J, Sher RB. Neuronal cell-cycle re-entry stratifies clinical trajectories in amyotrophic lateral sclerosis. Brain. 2026. doi:10.1093/brain/awag391
BibTeX
@article{PlessisBelair2026,
author = {Plessis-Belair, Jonathan and Sher, Roger B},
title = {Neuronal cell-cycle re-entry stratifies clinical trajectories in amyotrophic lateral sclerosis},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag391}
}
EUVIMED